Oday Hamid
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
-
- Melanoma and MAPK Pathways
Papers in
-
- Lymphoma Diagnosis and Treatment 6
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Lung Cancer Research Studies 2
- Co-authors
- Mary Laura Varterasian (3 shared papers)Joel Randolph Hecht (2 shared papers)Eric Peter Kaldjian (2 shared papers)Alex A. Adjei (1 shared paper)David Michael Waterhouse (1 shared paper)Judith S. Sebolt (1 shared paper)Ronald B. Natale (1 shared paper)John J. Rinehart (1 shared paper)
- Journals
- Annals of Oncology (4 papers)European Journal of Cancer (4 papers)Journal of Clinical Oncology (3 papers)Blood (2 papers)Targeted Oncology (2 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Oday Hamid
30 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 46
- Oncology 328
- Molecular Biology 289
- Otorhinolaryngology 22
- Surgery 161
- Genetics 95
Countries citing papers authored by Oday Hamid
This map shows the geographic impact of Oday Hamid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oday Hamid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oday Hamid more than expected).
Fields of papers citing papers by Oday Hamid
This network shows the impact of papers produced by Oday Hamid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oday Hamid. The network helps show where Oday Hamid may publish in the future.
Co-authors
The 25 scholars most cited alongside Oday Hamid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 541 | |
| 2 | 2017 | 141 | |
| 3 | 2003 | 116 | |
| 4 | 2023 | 102 | |
| 5 | 2005 | 91 | |
| 6 | 2017 | 76 | |
| 7 | 2019 | 73 | |
| 8 | 2017 | 62 | |
| 9 | 2016 | 56 | |
| 10 | 2018 | 46 | |
| 11 | 2020 | 43 | |
| 12 | 2011 | 30 | |
| 13 | 2013 | 26 | |
| 14 | 2015 | 25 | |
| 15 | 2020 | 23 | |
| 16 | 2004 | 21 | |
| 17 | 2014 | 15 | |
| 18 | 2021 | 15 | |
| 19 | 2019 | 8 | |
| 20 | 2011 | 7 |
About Oday Hamid
Oday Hamid is a scholar working on Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Dermatology, having authored 30 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Lung Cancer Research Studies (2 papers), Renal cell carcinoma treatment (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper), Cutaneous lymphoproliferative disorders research (1 paper) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Oncology (328 citations), Molecular Biology (289 citations), Otorhinolaryngology (22 citations), Surgery (161 citations) and Genetics (95 citations). Oday Hamid has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Mary Laura Varterasian, Joel Randolph Hecht, Eric Peter Kaldjian, Alex A. Adjei, David Michael Waterhouse, Judith S. Sebolt, Ronald B. Natale, John J. Rinehart, Mark B. Meyer and Patricia Mucci LoRusso. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, Blood and Targeted Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.